Rhythm Pharmaceuticals, Inc. (RYTM) Announced Q1 2026 Earnings on May 5, 2026, Reporting "Revenues for the quarter were $60 million."
Rhythm Pharmaceuticals announced Q1 2026 earnings, reporting $60.1 million in global net revenues and 5% sequential growth. The company noted a strong U.S. commercial launch, received marketing authorization in Europe, and has an ongoing review in Japan. Rhythm maintained its…